John O. Mascarenhas, MD | Authors

Articles

Improved Understanding of JAK2 Inhibition in Polycythemia Vera

November 09, 2017

John O. Mascarenhas, MD, associate professor of medicine, Icahn School of Medicine at Mount Sinai Hospital, discusses the optimal use of ruxolitinib (Jakafi) and the improved understanding of JAK2 inhibition of polycythemia vera.